169 related articles for article (PubMed ID: 11165141)
1. Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
Cao G; Kuriyama S; Gao J; Nakatani T; Chen Q; Yoshiji H; Zhao L; Kojima H; Dong Y; Fukui H; Hou J
Eur J Cancer; 2001 Jan; 37(1):140-7. PubMed ID: 11165141
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
4. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study.
Li W; Li DM; Chen K; Chen Z; Zong Y; Yin H; Xu ZK; Zhu Y; Gong FR; Tao M
BMC Cancer; 2012 Nov; 12():547. PubMed ID: 23173703
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
[TBL] [Abstract][Full Text] [Related]
6. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
[TBL] [Abstract][Full Text] [Related]
7. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
Biochem Biophys Res Commun; 2001 Oct; 287(4):1034-40. PubMed ID: 11573968
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
9. A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cells.
Cao G; Kuriyama S; Tsujinoue H; Chen Q; Mitoro A; Qi Z
Int J Cancer; 2000 Jul; 87(2):247-52. PubMed ID: 10861483
[TBL] [Abstract][Full Text] [Related]
10. Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging.
Park JH; Kim KI; Lee KC; Lee YJ; Lee TS; Chung WS; Lim SM; Kang JH
Cancer Biother Radiopharm; 2015 Feb; 30(1):8-15. PubMed ID: 25545853
[TBL] [Abstract][Full Text] [Related]
11. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene.
Su H; Chang JC; Xu SM; Kan YW
Hum Gene Ther; 1996 Mar; 7(4):463-70. PubMed ID: 8800740
[TBL] [Abstract][Full Text] [Related]
12. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
Gene Ther; 1999 Apr; 6(4):465-70. PubMed ID: 10476206
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional targeted gene therapy for hepatocellular carcinoma by adenovirus vector.
Kanai F
Mol Biotechnol; 2001 Jul; 18(3):243-50. PubMed ID: 11503518
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.
Kaneko S; Hallenbeck P; Kotani T; Nakabayashi H; McGarrity G; Tamaoki T; Anderson WF; Chiang YL
Cancer Res; 1995 Nov; 55(22):5283-7. PubMed ID: 7585589
[TBL] [Abstract][Full Text] [Related]
15. Construction of retroviral vector carrying HSV-tk gene under control of human AFP enhancer core sequence and human pgk promotor.
Gao J; Cao GW; Qi ZT; Qiu XF; Wu ZD; Du P; Yang WG; Cui L
World J Gastroenterol; 1997 Mar; 3(1):9-11. PubMed ID: 27006574
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice.
Ueki T; Nakata K; Mawatari F; Tsuruta S; Ido A; Ishikawa H; Nakao K; Kato Y; Ishii N; Eguchi K
Int J Mol Med; 1998 Apr; 1(4):671-5. PubMed ID: 9852281
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
Wills KN; Huang WM; Harris MP; Machemer T; Maneval DC; Gregory RJ
Cancer Gene Ther; 1995 Sep; 2(3):191-7. PubMed ID: 8528962
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of improved α-fetoprotein promoter-mediated tBid delivered by folate-PEI600-cyclodextrin nanopolymer vector in hepatocellular carcinoma.
Hu BG; Liu LP; Chen GG; Ye CG; Leung KK; Ho RL; Lin MC; Lai PB
Exp Cell Res; 2014 Jun; 324(2):183-91. PubMed ID: 24726886
[TBL] [Abstract][Full Text] [Related]
19. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
[TBL] [Abstract][Full Text] [Related]
20. Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.
Lu SY; Sui YF; Li ZS; Pan CE; Ye J; Wang WY
World J Gastroenterol; 2003 Apr; 9(4):688-91. PubMed ID: 12679911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
